TIVICAY PD FDA approval date
The FDA approved TIVICAY PD on 12 Jun 2020.
- FDA approval date
- 12 Jun 2020
- Source
- FDA record
Drug identity has not yet been verified against registry records
Also recorded as DOLUTEGRAVIR SODIUM
Included trials
No linked trials for this drug yet. Browse all trials
PDUFA dates and FDA decisions
| Date as reported | Drug / company | Event | Condition | Evidence |
|---|---|---|---|---|
| 2020-06-12Day | TIVICAY PD | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA213983", "applicant_as_listed_by_fda": "VIIV HLTHCARE", "brand_names": ["TIVICAY PD"], "active_ingredients": ["DOLUTEGRAVIR SODIUM"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20200612", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |